Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib Polyp Prevention in Resected Stage I Colon Cancer
NCT00087256Phase 3Terminated
- Sponsor
- NSABP Foundation
- Start
- Jul 2004
- Primary completion
- Apr 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in adenomatous polyp and colorectal cancer (CRC) comparing Celecoxib with Placebo (2 arms). Primary endpoint: Incidence of adenomatous polyps of the colon and rectum at 60 months. Started Jul 2004; status: terminated.
02
Drugs
celecoxib
03
Conditions
adenomatous polypcolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00087256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087256.